7Baggers
 Sensei Biotherapeutics to Host Virtual KOL Event to Discuss  GlobeNewswire Tue, 23 Sep 2025 11:31:48 GMT
 published on: 2025-09-17 04:59:04  newser.com Wed, 17 Sep 2025 09:59:04 GMT
 published on: 2025-09-14 04:11:00  newser.com Sun, 14 Sep 2025 09:11:00 GMT
 published on: 2025-09-13 22:03:31  newser.com Sun, 14 Sep 2025 03:03:31 GMT
 published on: 2025-09-13 20:13:22  newser.com Sun, 14 Sep 2025 01:13:22 GMT
 published on: 2025-09-13 10:48:38  newser.com Sat, 13 Sep 2025 15:48:38 GMT
 published on: 2025-09-13 05:15:04  Newser Sat, 13 Sep 2025 10:15:04 GMT
 published on: 2025-09-09 05:32:06  Newser Tue, 09 Sep 2025 10:32:06 GMT
 published on: 2025-09-08 21:09:46  Newser Tue, 09 Sep 2025 02:09:46 GMT
 published on: 2025-09-08 11:58:53  beatles.ru Mon, 08 Sep 2025 08:59:34 GMT
 published on: 2025-09-06 21:36:25  Newser Sun, 07 Sep 2025 02:36:25 GMT
 published on: 2025-09-05 05:51:29  Newser Fri, 05 Sep 2025 10:51:29 GMT
 published on: 2025-09-04 21:50:20  Newser Fri, 05 Sep 2025 02:50:20 GMT
 published on: 2025-09-04 00:32:13  Newser Thu, 04 Sep 2025 05:32:13 GMT
 published on: 2025-09-03 04:50:46  Newser Wed, 03 Sep 2025 09:50:46 GMT
 published on: 2025-09-02 10:40:59  Newser Tue, 02 Sep 2025 15:40:59 GMT
 published on: 2025-09-01 15:49:19  Newser Mon, 01 Sep 2025 20:49:19 GMT

Sensei Biotherapeutics, Inc
(NASDAQ:SNSE) 

SNSE stock logo

Sensei Biotherapeutics is developing a pipeline of medicines designed to fulfill the substantial potential of the immune system to defeat cancer.

Founded: 1999
CEO: John K Celebi  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends